Tempest Therapeutics, Inc. research brief

CIK 1544227 Copy CIK

Generated Nov. 13, 2026, 3:14 p.m. from up to 100 stored Form D disclosures. A CIK identifies a filer, not a single offering.

Current stored business address: BRISBANE California. Reported legal jurisdiction: DELAWARE. These do not establish investor residence or where funds were deployed.

• Oct. 14, 2026 · D · 0001213900-26-109190 · Source evidence

  Reported offering amount: 7500000 USD. Reported amount sold: 7500000 USD.

• June 23, 2026 · D · 0001193125-26-278048 · Source evidence

  Reported offering amount: 4056552 USD. Reported amount sold: 4056552 USD.

• April 3, 2026 · D · 0001231919-26-000307 · Source evidence

  Reported offering amount: 1999539 USD. Reported amount sold: 1999539 USD.

Reviewed offering links

• No independently reviewed offering relationship is recorded. Adjacent filings are not assumed to belong to one offering.

Citation: Form D Explorer, “Tempest Therapeutics, Inc. research brief,” CIK 1544227, retrieved Nov. 13, 2026, 3:14 p.m.. Cite the specific accessions used. No amounts have been summed.